NO20002188D0 - 1'-[4-[1-(4-Fluorfenyl)-1H-indol-3-yl]-1-butyl]- spiro[isobenzofuran-1(3H)-4'-piperidin]hydrohalogenider - Google Patents

1'-[4-[1-(4-Fluorfenyl)-1H-indol-3-yl]-1-butyl]- spiro[isobenzofuran-1(3H)-4'-piperidin]hydrohalogenider

Info

Publication number
NO20002188D0
NO20002188D0 NO20002188A NO20002188A NO20002188D0 NO 20002188 D0 NO20002188 D0 NO 20002188D0 NO 20002188 A NO20002188 A NO 20002188A NO 20002188 A NO20002188 A NO 20002188A NO 20002188 D0 NO20002188 D0 NO 20002188D0
Authority
NO
Norway
Prior art keywords
hydrohalides
isobenzofuran
indol
spiro
fluorophenyl
Prior art date
Application number
NO20002188A
Other languages
English (en)
Other versions
NO20002188L (no
NO325920B1 (no
Inventor
Niels Moerk
Ole Nielsen
Heidi Lopez De Diego
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20002188D0 publication Critical patent/NO20002188D0/no
Publication of NO20002188L publication Critical patent/NO20002188L/no
Publication of NO325920B1 publication Critical patent/NO325920B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002188A 1997-11-07 2000-04-27 1'-[4-[1-(4-Fluorfenyl)-1H-indol-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H)-4'-piperidin]hydrohalogenider NO325920B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK126797 1997-11-07
PCT/DK1998/000480 WO1999024436A1 (en) 1997-11-07 1998-11-06 1'-[4-[1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro [isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides

Publications (3)

Publication Number Publication Date
NO20002188D0 true NO20002188D0 (no) 2000-04-27
NO20002188L NO20002188L (no) 2000-06-14
NO325920B1 NO325920B1 (no) 2008-08-18

Family

ID=8102935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002188A NO325920B1 (no) 1997-11-07 2000-04-27 1'-[4-[1-(4-Fluorfenyl)-1H-indol-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H)-4'-piperidin]hydrohalogenider

Country Status (38)

Country Link
US (2) US6844352B2 (no)
EP (1) EP1044202B1 (no)
JP (1) JP3605358B2 (no)
KR (1) KR100399274B1 (no)
CN (1) CN1105115C (no)
AR (1) AR023010A1 (no)
AT (1) ATE288918T1 (no)
AU (1) AU749094B2 (no)
BG (1) BG64906B1 (no)
BR (1) BR9813949A (no)
CA (1) CA2308745C (no)
CZ (1) CZ288666B6 (no)
DE (1) DE69828999T2 (no)
DZ (1) DZ2642A1 (no)
EA (1) EA002092B1 (no)
EG (1) EG23791A (no)
ES (1) ES2234162T3 (no)
HR (1) HRP20000261B1 (no)
HU (1) HUP0100991A3 (no)
ID (1) ID25776A (no)
IL (1) IL135723A (no)
IS (1) IS2342B (no)
JO (1) JO2052B1 (no)
MA (1) MA25585A1 (no)
NO (1) NO325920B1 (no)
NZ (1) NZ504065A (no)
PE (1) PE130299A1 (no)
PL (1) PL190538B1 (no)
PT (1) PT1044202E (no)
RS (1) RS49777B (no)
SK (1) SK285245B6 (no)
TN (1) TNSN98201A1 (no)
TR (1) TR200001267T2 (no)
TW (1) TW483894B (no)
UA (1) UA64769C2 (no)
UY (1) UY25236A1 (no)
WO (1) WO1999024436A1 (no)
ZA (1) ZA9810116B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013789A1 (en) * 2000-08-15 2002-02-21 H. Lundbeck A/S Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]
WO2004026855A1 (en) * 2002-09-20 2004-04-01 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
EP1644026A4 (en) 2003-06-12 2007-10-24 Ms Science Corp SIGMA LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RECREATION
EP1913378A1 (de) * 2005-07-29 2008-04-23 Sigma-Aldrich Production GmbH Ionisierungsadditive enthaltende lc/ms-blends
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
BG104485A (en) 2001-01-31
TNSN98201A1 (fr) 2005-03-15
US20030055074A1 (en) 2003-03-20
DE69828999D1 (de) 2005-03-17
CN1278823A (zh) 2001-01-03
CN1105115C (zh) 2003-04-09
DE69828999T2 (de) 2005-07-21
TR200001267T2 (tr) 2000-09-21
US6844352B2 (en) 2005-01-18
YU23500A (sh) 2003-12-31
NO20002188L (no) 2000-06-14
CA2308745C (en) 2004-01-20
AU1022699A (en) 1999-05-31
PT1044202E (pt) 2005-04-29
EP1044202A1 (en) 2000-10-18
UA64769C2 (uk) 2004-03-15
BG64906B1 (bg) 2006-08-31
HRP20000261A2 (en) 2001-04-30
JO2052B1 (en) 1999-05-15
EP1044202B1 (en) 2005-02-09
HUP0100991A3 (en) 2003-03-28
JP2001522852A (ja) 2001-11-20
UY25236A1 (es) 2000-12-29
AR023010A1 (es) 2002-09-04
DZ2642A1 (fr) 2004-12-28
SK285245B6 (sk) 2006-09-07
CZ20001663A3 (cs) 2000-10-11
ZA9810116B (en) 1999-05-07
IL135723A (en) 2005-11-20
HUP0100991A2 (hu) 2001-09-28
EG23791A (en) 2007-08-13
MA25585A1 (fr) 2002-12-31
RS49777B (sr) 2008-06-05
ES2234162T3 (es) 2005-06-16
ID25776A (id) 2000-11-02
PL190538B1 (pl) 2005-12-30
IS5460A (is) 2000-04-18
KR100399274B1 (ko) 2003-09-26
HRP20000261B1 (en) 2009-04-30
JP3605358B2 (ja) 2004-12-22
PE130299A1 (es) 1999-12-16
IS2342B (is) 2008-02-15
TW483894B (en) 2002-04-21
NZ504065A (en) 2002-05-31
HK1034075A1 (en) 2001-10-12
IL135723A0 (en) 2001-05-20
CA2308745A1 (en) 1999-05-20
KR20010031791A (ko) 2001-04-16
WO1999024436A1 (en) 1999-05-20
PL340220A1 (en) 2001-01-15
BR9813949A (pt) 2000-09-26
CZ288666B6 (cs) 2001-08-15
SK6462000A3 (en) 2000-10-09
ATE288918T1 (de) 2005-02-15
NO325920B1 (no) 2008-08-18
EA200000502A1 (ru) 2000-10-30
US20050171135A1 (en) 2005-08-04
EA002092B1 (ru) 2001-12-24
AU749094B2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
NO20002188L (no) 1'-[4-[1-(4-Fluorfenyl)-1H-indol-3-yl]-1-butyl]- spiro[isobenzofuran-1(3H)-4'-piperidin]hydrohalogenider
DE69732113D1 (de) Schnelllösliche tablette enthaltend galanthaminhydrobromid
DE60039247D1 (de) Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer
EP0341936A3 (en) Tilt adjustment mechanism for object lens driving
AU8123291A (en) Stoppable flushing mechanism with assured minimal flow
GB8828654D0 (en) Removable guide post
GB8913960D0 (en) Sensor unit for traffic control of an automatic guide vehicle
DK1044202T3 (da) 1'-[4-[1-(4-Fluorphenyl)-1H-indol-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4'-piperidin]hydrohalogenider
AU1578799A (en) Anchoring mechanism for a guide post
FI974470A7 (fi) Uusia spiro (2H-1-bentsopyraani-2,4'-piperidiini)-4(3H)-oni johdannaisia, niiden happoadditiosuoloja ja niitä sisältäviä farmaseuttisia koostumuksia
SI1044202T1 (en) 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl) -1-butyl)-spiro isobenzofuran- 1(3h),4'- piperidine) hydrohalogenides
HUP0101706A3 (en) Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks
AU4655589A (en) Device for closing an orifice consisting essentially of a section of a thermoplastic tube
GB2226228B (en) Device for the vertical adjustment of an upper safety-belt fitting
FI951551A7 (fi) Laite istuimen automaattista vaakasuoraa säätämistä varten
AU2001279607A1 (en) Pharmaceutical composition containing 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl) -1-butyl)-spiro(isobenzofuran-1(3h),4'-piperidine)
KR940007916U (ko) 자동문의 높이조절장치
HUP9902376A3 (en) Process for producing n-(1,1-dimethyl)-4-[[s'-ethoxi-4-cis-[2-(4-morpholino)-ethoxi]-2'-oxospiro[cyclohexane-1,3'-[3h]indole]-1'(2'h)yl]-sulfonyl]-3-methoxybenzamide and its salts
KR970009880U (ko) 높이 조절이 용이한 건축용 인서트
KR900011961U (ko) 운전석 의자의 높이 및 거리조정 장치
CS49692A3 (en) Device for accurate adjustment of height of building machines guide stringpick-up
KR900012854U (ko) 복사기의 급지 안내용 펜스간격 자동조절 장치
IL103869A0 (en) Device for raising a toilet seat
SE9200709D0 (sv) Anordning foer lutningsinstaellning av en baerare
KR970010830U (ko) 렌즈의 시준거리 미세 조정장치

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

MM1K Lapsed by not paying the annual fees